title: PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models.
abstract: Unlike previous pandemic viruses, the 2009 H1N1 pandemic influenza virus does not code for the virulence factor PB1-F2. The genome of the 2009 H1N1 virus contains three stop codons preventing PB1-F2 expression; however, PB1-F2 production could occur following genetic mutation or reassortment. Thus, it is of great interest to understand the impact that expression of the PB1-F2 protein might have in the context of the 2009 pandemic influenza virus, A/California/04/2009 (Cal/09). We have addressed this question by generating two Cal/09 viruses with productive PB1-F2 open reading frames containing either an asparagine at position 66 of PB1-F2 (66N) or a serine at position 66 (66S): this N66S change has previously been shown to be associated with increased virulence in mice. We used these viruses to investigate the effect on virulence conferred by expression of the 66N or the 66S PB1-F2 protein in both in vitro and in vivo systems. Our results show enhanced replication of the 66S virus in A549 cells, while studies of BALB/c and DBA/2 mice and ferrets revealed no significant differences in symptoms of infection with wild-type Cal/09 versus the 66N or 66S virus variant. Also, coinfection of mice with Streptococcus pneumoniae and the different viruses (recombinant wild-type [rWT] Cal/09 and the 66N and 66S viruses) did not result in significant differences in mortality. Mice infected with either PB1-F2-expressing virus did demonstrate altered protein levels of proinflammatory cytokines; differences were observed to be greater in infection caused by the 66S virus. In summary, our study demonstrates that PB1-F2 expression by the Cal/09 virus modulates the immune response to infection while having a minimal effect on virus virulence in two mammalian models.
authors.affiliation: Department of Microbiology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029-6574, USA.
authors.forename: Rong
authors.initials: R
authors.lastname: Hai
authors.forename: Mirco
authors.initials: M
authors.lastname: Schmolke
authors.forename: Zsuzsanna T
authors.initials: ZT
authors.lastname: Varga
authors.forename: Balaji
authors.initials: B
authors.lastname: Manicassamy
authors.forename: Taia T
authors.initials: TT
authors.lastname: Wang
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Belser
authors.forename: Melissa B
authors.initials: MB
authors.lastname: Pearce
authors.forename: Adolfo
authors.initials: A
authors.lastname: García-Sastre
authors.forename: Terrence M
authors.initials: TM
authors.lastname: Tumpey
authors.forename: Peter
authors.initials: P
authors.lastname: Palese
mesh_terms: D000818:Animals; D002460:Cell Line; D018389:Codon, Nonsense; D004195:Disease Models, Animal; D005260:Female; D005289:Ferrets; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics / Q000472:pathogenicity*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D016297:Mutagenesis, Site-Directed; D009976:Orthomyxoviridae Infections / Q000401:mortality / Q000473:pathology* / Q000821:virology*; D011008:Pneumococcal Infections / Q000401:mortality / Q000473:pathology; D013296:Streptococcus pneumoniae / Q000472:pathogenicity; D016019:Survival Analysis; D014764:Viral Proteins / Q000096:biosynthesis* / Q000235:genetics; D014774:Virulence; D037521:Virulence Factors / Q000096:biosynthesis* / Q000235:genetics; D014779:Virus Replication
chemical_list: D018389:Codon, Nonsense; C442816:PB1-F2 protein, Influenza A virus; D014764:Viral Proteins; D037521:Virulence Factors